Xueliang Fang

发表

The PDBbind database: methodologies and updates.

Renxiao Wang, Xueliang Fang, Yipin Lu, 2005, Journal of medicinal chemistry.

Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cells.

Shaomeng Wang, Xueliang Fang, Dajun Yang, 2007, Cancer letters.

The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures.

Renxiao Wang, Xueliang Fang, Yipin Lu, 2004, Journal of medicinal chemistry.

Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.

Dajun Yang, Xueliang Fang, Renxiao Wang, 2004 .

Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.

Xueliang Fang, Renxiao Wang, Shaomeng Wang, 2004, Analytical biochemistry.

CHMIS-C: a comprehensive herbal medicine information system for cancer.

Xueliang Fang, Shaomeng Wang, Lei Shao, 2005, Journal of medicinal chemistry.

Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.

Xueliang Fang, Xueliang Fang, Shaomeng Wang, 2003, Journal of medicinal chemistry.

Identification of Novel Neuroprotective Agents Using Pharmacophore Modeling

Shaomeng Wang, A. Faden, Xueliang Fang, 2005, Chemistry & biodiversity.

Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.

Dajun Yang, Xueliang Fang, Renxiao Wang, 2004, Journal of medicinal chemistry.

Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy.

Xueliang Fang, Su Qiu, Xueliang Fang, 2006, Journal of medicinal chemistry.

USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma

Xiao-jing Yang, Na Liu, Jun Ma, 2022, Nature communications.

Web-Based Tools for Mining the NCI Databases for Anticancer Drug Discovery

Hui Zhang, Lei Shao, Shaomeng Wang, 2004, J. Chem. Inf. Model..

A Web-Based 3D-Database Pharmacophore Searching Tool for Drug Discovery

Shaomeng Wang, Xueliang Fang, Xueliang Fang, 2002, J. Chem. Inf. Comput. Sci..

Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chloro-2-methylellipticinium acetate (CMEP).

Shaomeng Wang, Xueliang Fang, Dajun Yang, 2007, Biochemical pharmacology.

Prediction of surface tension in metallic and ionic melts in thermophysical database system

T. Zhou, Xueliang Fang, Dingxu Shi, 1998 .

An Extensive Test of 14 Scoring Functions Using the PDBbind Refined Set of 800 Protein-Ligand Complexes

Shaomeng Wang, Renxiao Wang, Xueliang Fang, 2004, J. Chem. Inf. Model..

A deep learning-based radiomic nomogram for prognosis and treatment decision in advanced nasopharyngeal carcinoma: A multicentre study

D. Dong, S. Liang, Wei Jiang, 2021, EBioMedicine.

Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold.

Liu Liu, Shaomeng Wang, Xueliang Fang, 2012, Journal of medicinal chemistry.

An Extensive Test for 14 Scoring Functions Using the PDBbind Refined Set of 800 Protein—Ligand Complexes.

Renxiao Wang, Xueliang Fang, Yipin Lu, 2005 .

Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy.

Xueliang Fang, Su Qiu, Xueliang Fang, 2006, Journal of medicinal chemistry.